High interleukin-10 serum levels are associated with fatal outcome in patients after bone marrow transplantation

Bone Marrow Transplantation

Volumn 20, Issue 5, 1997, Pages 365-368

  Hempel, L ^a   Korholz D ^b   Nussbaum P ^c   Bonig H ^b   Burdach, S ^b,d   Zintl, F ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c Institute of Pathology   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Bone marrow transplantation; Interleukin 10; Neopterin; Sepsis

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 10; NEOPTERIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ACUTE PHASE RESPONSE; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BLOOD LEVEL; CELLULAR IMMUNITY; CHILD; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; DISEASE COURSE; EWING SARCOMA; FATALITY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOMODULATION; INFECTION; MALE; NONHODGKIN LYMPHOMA; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; SEPTIC SHOCK; T LYMPHOCYTE; TREATMENT OUTCOME;

EID: 1842376280     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700902     Document Type: Article

References (20)

1. De Waal Malefyt R, Haanen J, Spits H et al. Interleukin-10 and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down regulation of class II major histocompatibility complex expression. J Exp Med 1991; 174: 915-924.
2. + T cell clones and resting T cells. J Immunol 1993; 150: 4754-4765.
3. Hempel L, Körholz D, Burdach S et al. Interleukin-10 directly inhibits interleukin-6 production by T cells. Scand J Immunol 1995; 41: 462-466.
4. Kühn R, Lohler J, Rennick D et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75: 263-274.
5. Berg DJ, Kuhn R, Rajewsky K et al. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxin shock and the Schwartzman reaction but not endotoxin tolerance. J Clin Invest 1995; 96: 2339-2347.
6. Bourrie B, Bouaboula M, Benoit JM et al. Enhancement of endotoxin-induced interleukin-10 production by SR 31737A, a sigma ligand. Eur J Immunol 1995; 25: 2882-2887.
7. van der Poll T, Marchant A, Buurman WA et al. Endogenous IL-10 protects mice from death during septic peritonitis. J Immunol 1995; 155: 5397-5401.
8. Lehmann AK, Halstensen A, Sornes S et al. High levels of interleukin 10 in serum associated with fatality in meningococcal disease. Infect Immunol 1995; 63: 2109-2112.
9. Marchant A, Alegre ML, Hakim A et al. Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock. J Clin Immunol 1995; 15: 266-273.
10. van Deuren M, van der Ven-Jongekrijg J, Bartelink AK et al. Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections. J Infect Dis 1995: 172: 433-439.
11. Del Prete G, De Carli M, Almerigogna F et al. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993; 150: 353-360.
12. De Waal Malefyt R, Abrams J, Bennett B et al. Interleukin-10 inhibits cytokine synthesis by human monocytes: an auto-regulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174: 1209-1220.
13. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse helper T cell. IV Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170: 2081-2095.
14. Castenskiold EC, Kelsey SM, Collins PW et al. Functional hyperactivity of monocytes after bone marrow transplantation - possible relevance for the development of posttransplant complications or relapse. Bone Marrow Transplant 1995; 15: 879-884.
15. Gomez-Jimenez J, Martin MC, Saun R et al. Interleukin-10 and the monocyte/macrophage-induced inflammatory response in septic shock. J Infect Dis 1995; 171: 472-475.
16. Haupt W, Hohenberger W, Klein P, Christou NV. Detection of neopterin, interleukin-6 and acute-phase proteins as parameters of potential monocyte activation in preoperative patients. Infection 1995; 23: 263-266.
17. Pechumer H, Leinisch E, Bender-Götze C, Ziegler-Heitbrock HW. Recovery of monocytes after bone marrow transplantation - rapid reappearance of tumor necrosis factor alpha and interleukin 6 production. Transplantation 1991; 52: 698-704.
18. Oehler L, Foedinger M, Koeller M et al. Interleukin-10 inhibits spontaneous colony-forming unit granulocyte-macrophage growth from human peripheral blood mononuclear cells by suppression fo endogenous GM-CSF release. Blood 1997; 89: 1147-1153.
19. Körholz D, Schneider M, Giesecke E et al. Induction of remission by cyclosporin A in a patient with a hemophagocytic syndrome. Eur J Paediat 1995; 154: 778 (Abstr.).
20. Romani L, Puccetti P, Menacci A et al. Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. J Immunol 1994; 152: 3514-3521.